Ross Norris

3.2k total citations
79 papers, 2.5k citations indexed

About

Ross Norris is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Ross Norris has authored 79 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 19 papers in Pediatrics, Perinatology and Child Health and 11 papers in Infectious Diseases. Recurrent topics in Ross Norris's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pain Management and Opioid Use (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ross Norris is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Pain Management and Opioid Use (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Ross Norris collaborates with scholars based in Australia, United States and United Kingdom. Ross Norris's co-authors include Robyn K. Chiswell, Maree J. Smith, G. R. Shaw, Alan A. Seawright, Jennifer Martin, G. Eaglesham, Jason A. Roberts, Bruce Charles, David L. Paterson and Michael R. Moore and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Ross Norris

77 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Norris Australia 24 956 503 329 321 285 79 2.5k
Yedidia Bentur Israel 26 132 0.1× 201 0.4× 166 0.5× 27 0.1× 203 0.7× 116 2.6k
Neil Spooner United Kingdom 29 69 0.1× 626 1.2× 223 0.7× 71 0.2× 270 0.9× 67 3.4k
Richard O. Jenkins United Kingdom 31 606 0.6× 109 0.2× 646 2.0× 16 0.0× 33 0.1× 142 3.3k
Thressa C. Stadtman United States 50 258 0.3× 269 0.5× 935 2.8× 17 0.1× 187 0.7× 162 9.6k
Kazimierz Wróbel Mexico 36 114 0.1× 166 0.3× 773 2.3× 15 0.0× 83 0.3× 160 4.3k
Patrick Poulin Canada 32 83 0.1× 398 0.8× 509 1.5× 39 0.1× 291 1.0× 82 3.8k
C.M. Chavez-Eng United States 18 97 0.1× 1.3k 2.6× 314 1.0× 9 0.0× 334 1.2× 31 6.2k
P. Fürst Germany 41 223 0.2× 92 0.2× 760 2.3× 25 0.1× 302 1.1× 190 5.1k
Tohru Kikuchi Japan 37 184 0.2× 1.1k 2.2× 49 0.1× 90 0.3× 14 0.0× 276 5.1k
Katarzyna Wróbel Mexico 34 115 0.1× 151 0.3× 755 2.3× 13 0.0× 80 0.3× 144 3.5k

Countries citing papers authored by Ross Norris

Since Specialization
Citations

This map shows the geographic impact of Ross Norris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Norris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Norris more than expected).

Fields of papers citing papers by Ross Norris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Norris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Norris. The network helps show where Ross Norris may publish in the future.

Co-authorship network of co-authors of Ross Norris

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Norris. A scholar is included among the top collaborators of Ross Norris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Norris. Ross Norris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Graham, et al.. (2022). Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry. SHILAP Revista de lepidopterología. 24. 57–64. 7 indexed citations
2.
Williams, Kenneth M., Garry G. Graham, Ross Norris, et al.. (2019). Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection. Journal of Chromatography B. 1126-1127. 121764–121764. 14 indexed citations
3.
Gould, Michael K., Andrew N. Ginn, Debbie Marriott, Ross Norris, & Indy Sandaradura. (2019). Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae. International Journal of Antimicrobial Agents. 54(2). 240–244. 9 indexed citations
4.
Imani, Sahand, Hergen Buscher, Richard O. Day, et al.. (2018). An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy. European Journal of Clinical Microbiology & Infectious Diseases. 37(11). 2171–2175. 23 indexed citations
5.
McLachlan, Andrew J., et al.. (2017). Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats. PLoS ONE. 12(6). e0178783–e0178783. 6 indexed citations
6.
Hennig, Stefanie, Ross Norris, Michael Lobb, et al.. (2017). Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?. Cancer Chemotherapy and Pharmacology. 80(1). 15–25. 12 indexed citations
7.
Haywood, Alison, et al.. (2015). Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer. Clinical Therapeutics. 37(11). 2468–2475. 15 indexed citations
8.
Duley, John A., Ming Ni, Catherine Shannon, et al.. (2015). Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males. European Journal of Pharmaceutical Sciences. 81. 36–41. 19 indexed citations
9.
Tate, Jillian R., et al.. (2014). Clinical Consequences of a Miscalibrated Digoxin Immunoassay. Therapeutic Drug Monitoring. 37(1). 104–109. 4 indexed citations
10.
Norris, Ross, Miles Paul, Roy George, et al.. (2012). A stable-isotope HPLC–MS/MS method to simplify storage of human whole blood samples for glutathione assay. Journal of Chromatography B. 898. 136–140. 16 indexed citations
11.
Khan, Sohil, Helen Heussler, Treasure McGuire, et al.. (2011). Therepeutic Options in the Management of Sleep Disorders in Visually Impaired Children: A Systematic Review. Griffith Research Online (Griffith University, Queensland, Australia). 11 indexed citations
12.
Lobb, Michael, et al.. (2011). Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients. Therapeutic Drug Monitoring. 33(4). 547–547. 1 indexed citations
13.
Norris, Ross, Jennifer Martin, John E. Ray, et al.. (2010). Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development. Therapeutic Drug Monitoring. 32(5). 615–623. 31 indexed citations
14.
Charles, Bruce, et al.. (2009). Determination of risperidone and 9‐Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders. Biomedical Chromatography. 23(9). 929–934. 17 indexed citations
15.
Norris, Ross, Xiaonian Xiao, William M. Hague, David McIntyre, & B. G. Charles. (2004). A new HPLC method for analysis of metformin in cord plasma - application to placental transfer studies. Array. 31(1). 57–58. 1 indexed citations
16.
Norris, Ross, G. Eaglesham, G. R. Shaw, et al.. (2001). Extraction and purification of the zwitterions cylindrospermopsin and deoxycylindrospermopsin from Cylindrospermopsis raciborskii. Environmental Toxicology. 16(5). 391–396. 54 indexed citations
17.
Shaw, G. R., Mitchell R. Smith, Ross Norris, et al.. (2000). Degradation of the cyanobacterial toxin cylindrospermopsin, from Cylindrospermopsis raciborskii, by chlorination. Toxicon. 38(9). 1203–1213. 51 indexed citations
18.
Taylor, Paul J., Paul Salm, Ross Norris, Peter J. Ravenscroft, & Susan M. Pond. (1994). Comparison of High-Performance Liquid Chromatography and Monoclonal Fluorescence Polarization Immunoassay for the Determination of Whole-Blood Cyclosporin A in Liver and Heart Transplant Patients. Therapeutic Drug Monitoring. 16(5). 526–530. 8 indexed citations
19.
Salm, Paul, et al.. (1993). A Reliable High-Performance Liquid Chromatography Assay for High-Throughput Routine Cyclosporin A Monitoring in Whole Blood. Therapeutic Drug Monitoring. 15(1). 65–69. 19 indexed citations
20.
Norris, Ross, et al.. (1992). The influence of vancomycin concentration and the pH of plasma on vancomycin protein binding. Journal of Pharmacological and Toxicological Methods. 28(1). 57–60. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yedidia Bentur Breakdown of academic impact, for papers by Neil Spooner Breakdown of academic impact, for papers by Richard O. Jenkins Breakdown of academic impact, for papers by Thressa C. Stadtman Breakdown of academic impact, for papers by Kazimierz Wróbel Breakdown of academic impact, for papers by Patrick Poulin Breakdown of academic impact, for papers by C.M. Chavez-Eng Breakdown of academic impact, for papers by P. Fürst Breakdown of academic impact, for papers by Tohru Kikuchi Breakdown of academic impact, for papers by Katarzyna Wróbel
Rankless by CCL
2026